Disclosure of related party transaction is not applicable as the company listed its shares on BSE SME Platform.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
KMS Medisurgi Ltd has informed BSE that the disclosure of related party transactions under Regulation 23(9) of SEBI LODR is not applicable to it for the financial year ended March 31, 2025. The company explains that as per Regulation 15(2) of SEBI Listing Obligations and Disclosure Requirements Regulations, 2015, entities listed on the SME Exchange are exempt from several corporate governance provisions, including related party transaction disclosures. Since KMS Medisurgi is listed on the BSE SME Platform, these disclosure requirements do not apply. The letter is signed by Director Siddharth Kanakia and is filed as a compliance confirmation rather than a substantive corporate action.
This is a routine compliance filing with no material impact on shareholders or stock price. Investors should note that related party transaction details will not be publicly disclosed for FY25, which is normal for SME-listed companies and not a red flag in itself.